JRC Publications Repository

JRC Publications Repository >

Browsing by Author BRUCHERTSEIFER Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 33 to 52 of 93
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2013DNA double strand break assessment by yH2AX-foci quantification after alpha-particle emitter Ac-225 and electron emitter Lu-177 somatostatin receptor targeted radiotherapy correlates with cell death and apoptosis in vitroGRAF Franziska; FAHRER Jörg; MAUS Stephan; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; HUELSENBECK Johannes; SCHRECKENBERGER M, et alContributions to Conferences
2014DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapyGRAF Franziska; FAHRER Jörg; MAUS Stephan; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; HUELSENBECK Johannes; SCHRECKENBERGER M, et alArticles in Journals
2012Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrestVALLON M.; SEIDL C.; BLECHERT B.; LI Zhoulei; GILBERTZ K.-P.; BAUMGART Anja; AICHLER M; FEUCHTINGER A; GAERTNER F. C.; BRUCHERTSEIFER Frank, et alArticles in Journals
2013Exploring the solution behavior of f-element coordination compounds: a case study on some trivalent rare earth and plutonium complexesLÖBLE Matthias; ONA-BURGOS Pascual; FERNANDEZ Ignacio; APOSTOLIDIS Christos; MORGENSTERN Alfred; WALTER Olaf; BRUCHERTSEIFER Frank; KADEN Peter; VITOVA T.; ROTHE J., et alArticles in Journals
2012Feasibility of 99Mo production by proton-induced fission of 232ThABBAS Kamel; HOLZWARTH Uwe; SIMONELLI Federica; KOZEMPEL JAN; CYDZIK Izabela; BULGHERONI A.; COTOGNO Giulio; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; MORGENSTERN AlfredArticles in Journals
2010A feasibility study of a new method for production of U-230/TH-226 fro alpha-immunotherapy applicationsABBAS Kamel; SIMONELLI Federica; CYDZIK Izabela; KOZEMPEL JAN; APOSTOLIDIS Christos; ZIELINSKA Barbara; BRUCHERTSEIFER Frank; MORGENSTERN AlfredContributions to Conferences
2013Functionalized NaA nanozeolites as carriers for alpha emitting radionuclides.PIOTROWSKA A; LESZCZUK Edyta; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BILEWICZ AleksanderContributions to Conferences
2013Functionalized NaA Nanozeolites Labeled with 224,225Ra for Targeted Alpha TherapyAGATA Piotrowska; EDYTA Leszczuk; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BILEWICZ AleksanderArticles in Journals
2007Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, IrradiationSUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M.Articles in Journals
2013Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay seriesSULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et alArticles in Journals
2012High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumRAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2013High Resolution microSPECT imaging of Bi-213DE SWART J; SEGBERS M; MORGENSTERN Alfred; VAN DER HAVE F; CHAN Ho-Sze; BERNDSEN S.c.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.Contributions to Conferences
2010Immunoliposomal Delivery of 213Bi for Alpha-emitter Targeting of Metastatic Breast CancerLINGAPPA M.; SONG H.; THOMPSON S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G.Articles in Journals
2007An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in Journals
2009In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapyBRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS ChristosContributions to Conferences
2012In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapyGRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER MatthiasContributions to Conferences
2009Intravesical a-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude MicePFOST Birgit; SEIDI Christof; AUTENRIETH Michael; SAUR Dieter; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SCHWAIGER Markus; SENEKOWITSCH-SCHMIDTKE ReingardArticles in Journals
2010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2010Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2013Measurement and modelling of the cross sections for the reaction 230Th(3He,3n)230UMORGENSTERN Alfred; ABBAS Kamel; SIMONELLI Federica; CAPOTE NOY R.; SIN M.; ZIELINSKA B.; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
Showing results 33 to 52 of 93

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top